Platelet Rich Plasma (PRP) Market Dynamics, SWOT Analysis and Competitive Insights till 2025

Posted on 2020-12-03 by researchinsights in Healthcare // 0 Comments

Felton, Calif., USA, Dec. 03, 2020 — /EPR Network/ —

– Global Platelet Rich Plasma (PRP) Market is estimated to reach USD 647.01 million by 2025 owing to the growing prevalence of orthopedic disorders like knee osteoarthritis, achilles tendinopathy, rotator cuff tears and increasing application of platelet rich plasma in cosmetic surgery. Platelet rich plasma is a common treatment at present in the cosmetic (dermatological) field.

It stimulates fibroblasts in the skin and makes them produce collagen fibers since (PRP) Platelet Rich Plasma is made from the patient’s body, the treatment is considered very safe. It is prepared by separating the blood sample, which separates platelet rich plasma from the platelet poor plasma and the red blood cells due to the differences. It comprises proteins that act as cell adhesive molecules like fibrin, vitronectin, and fibronectin.

Access Platelet Rich Plasma (PRP) Market Report with TOC @ https://www.millioninsights.com/industry-reports/platelet-rich-plasma-prp-market

Platelet rich plasma therapy has gained traction due to its wide application with no side-effects. It is also used for treating injured tendons, joints, muscles, and ligaments. PRP therapy also reduces patients’ low back pain and help them recover soon. It is also extensively used in cases of baldness that increases the blood flow and supports in hair growth.

Since, the patient prefer minimally invasive surgeries, the cost of technological use is high. On the other hand, speedy and efficient healing post a surgery remains therapeutic-stage of great importance for the caretakers and PRP has been serving the cause effectively. The prevalence of orthopedic disorders that require surgery, continue to grow along with the trend of cosmetic surgeries in developed regions with a vast geriatric population.

Platelet Rich Plasma industry is predicted to attain new heights across geographies. Leukocyte rich PRP has witnessed higher growth since it stimulates the growth of tissues that help in the treatment of soft tissue flaws of human body. The major driving factors of the market are the growing elderly population, increase in occurrence of sports and orthopedic injuries, the increasing number of cosmetic surgeries, technological advancements and rise in awareness regarding PRP therapies.

Platelet Rich Plasma Product Outlook (Revenue, USD Million, 2014 – 2025)

Pure PRP
Leukocyte-Rich PRP
Leukocyte-Rich Fibrin

Platelet Rich Plasma Application Outlook (Revenue, USD Million, 2014 – 2025)

Orthopedics
Cosmetic Surgery & Dermatology
Ophthalmic Surgery
Neurosurgery
General surgery
Others

The key platelet rich plasma (PRP) industry players profiled here are Arthrex, Inc., Zimmer Biomet, Harvest Technologies Corporation, DePuySynthes, Inc., Stryker Corporation, AdiStem Ltd., ISTO Biologics, Cesca Therapeutics, Inc., Exactech Inc., and Nuo Therapeutics.

Request a Sample Copy of Platelet Rich Plasma (PRP) Market Report @ https://www.millioninsights.com/industry-reports/platelet-rich-plasma-prp-market/request-sample

Platelet Rich Plasma Regional Outlook (Revenue, USD Million, 2014 – 2025)

North America
U.S.
Canada
Europe
Germany
UK
Asia Pacific
China
Japan
Latin America
Brazil
Mexico
MEA
South Africa

Visit Our Blog: https://marketreportsassistance.wordpress.com

Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

Matched content

Editor’s pick